Search results
KalVista shares sink after ending drug trial for hereditary disease
Reuters via Yahoo! Philippines News· 2 years agoThe drug developer cited increased levels of liver enzymes in some patients, which could lead to liver damage if kept unchecked, for the termination. "The current formulation will not meet our ...